|
|
|
41
|
A992Q
|
DETRUSITOL 2MG SR TAB (PFI) TOLTERODINE (C)
|
TOLTERODINE
|
DETRUSITOL
|
30'S
|
C
|
67.14
|
2.2381
|
TABSR
|
0
|
BOX
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
1208
|
ANTICHOLINERGIC AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
ANTICHOLINERGIC AGENTS
|
|
|
|
|
40
|
A992R
|
DETRUSITOL SR 2MG TAB (PFI/SBI) TOLTERODINE
|
TOLTERODINE
|
DETRUSITOL SR
|
30'S
|
C
|
66.54
|
2.22
|
TABLET
|
0
|
TAB
|
PFI
|
PFIZER CORPORATION
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
120808
|
ANTIMUSCARINICS/ANTISPASMODICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
AUTONOMIC DRUGS
|
|
|
|
|
41
|
A992R
|
DETRUSITOL 2MG SR TAB (PFI) TOLTERODINE (C)
|
TOLTERODINE
|
DETRUSITOL
|
30'S
|
C
|
67.14
|
2.2381
|
TABSR
|
0
|
BOX
|
PFI
|
PFIZER CORPORATION
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
1208
|
ANTICHOLINERGIC AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
ANTICHOLINERGIC AGENTS
|
|
|
|
|
40
|
A9933
|
DETRUSITOL SR 4MG TAB (PFI/SBI) TOLTERODINE
|
TOLTERODINE
|
DETRUSITOL SR
|
30'S
|
C
|
133.06
|
4.44
|
TABLET
|
0
|
TAB
|
PFI
|
PFIZER CORPORATION
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
120808
|
ANTIMUSCARINICS/ANTISPASMODICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
AUTONOMIC DRUGS
|
|
|
|
|
40
|
A993G
|
DETRUSITOL 4MG TAB (PFI/STO) TOLTERODINE
|
TOLTERODINE
|
DETRUSITOL
|
30'S
|
C
|
133.06
|
4.44
|
TABLET
|
0
|
TAB
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
120808
|
ANTIMUSCARINICS/ANTISPASMODICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
AUTONOMIC DRUGS
|
|
|
|
|
41
|
A993G
|
DETRUSITOL 4MG TAB (PFI) TOLTERODINE (C)
|
TOLTERODINE
|
DETRUSITOL
|
30'S
|
C
|
134.26
|
4.4753
|
TAB
|
0
|
BOX
|
PFI
|
PFIZER CORPORATION
|
STO
|
BRYDEN STOKES LTD
|
|
1208
|
ANTICHOLINERGIC AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
ANTICHOLINERGIC AGENTS
|
|
|
|
|
41
|
A993H
|
DETRUSITOL LA 4MG CAP (PFI) TOLTERODINE (C)
|
TOLTERODINE
|
DETRUSITOL LA
|
30'S
|
C
|
134.26
|
4.4753
|
CAP
|
0
|
BOX
|
PFI
|
PFIZER CORPORATION
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
1208
|
ANTICHOLINERGIC AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
ANTICHOLINERGIC AGENTS
|
|
|
|
|
40
|
B001D
|
CABERGOLINE 0.5MG TAB (TMP/AHI)
|
CABERGOLINE
|
CABERGOLINE
|
4'S
|
BQ
|
30.83
|
7.71
|
TABLET
|
0
|
TAB
|
TMP
|
THE MADRAS PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
283620
|
DOPAMINE RECEPTOR AGONIST
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
B001E
|
APO-CABERGOLINE 0.5MG TAB (APO) CAB (C)
|
CABERGOLINE
|
APO-CABERGOLINE
|
8'S
|
C
|
27.73
|
3.4659
|
TAB
|
32
|
BOTT
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
283620
|
DOPAMINE RECEPTOR AGONIST
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
DOPAMINE RECEPTOR AGONIST
|
|
|
|
|
40
|
B011AM
|
ABACAVIR 300MG TAB (CIP/AHI)
|
ABACAVIR
|
ABACAVIR
|
60'S
|
BL
|
86.82
|
1.45
|
TABLET
|
0
|
TAB
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08180820
|
NRTI
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
B011AM
|
ABACAVIR 300MG TAB (CIP) (BL)
|
ABACAVIR
|
ABACAVIR
|
60'S
|
BL
|
129.39
|
2.1565
|
TAB
|
60
|
BOX
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08180820
|
NRTI
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
NRTI
|
|
|
|
|
40
|
B011DK
|
3TC 150MG TAB (GSK/COL) LAMIVUDINE
|
LAMIVUDINE
|
3TC
|
60'S
|
BL
|
42.84
|
0.71
|
TABLET
|
0
|
TAB
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
08180820
|
NRTI
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
40
|
B011DX
|
ZIDINE 300MG (EMC/COL) ZIDOVUDINE
|
ZIDOVUDINE
|
ZIDINE
|
60'S
|
BL
|
19.03
|
0.32
|
TABLET
|
0
|
TAB
|
EMC
|
EMCURE PHARMACEUTICALS LTD
|
COL
|
COLLINS LTD
|
|
08180820
|
NRTI
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
40
|
B011EG
|
APO-LAMIVUDINE 150MG TAB (APO/COL)
|
LAMIVUDINE
|
APO-LAMIVUDINE
|
60'S
|
B
|
83.02
|
1.3837
|
TABLET IMMED
|
|
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
8180820
|
NRTI
|
2022-04-01
|
2024-03-31
|
Add to Contract as Cat B
|
Oral
|
|
NRTI
|
2022-12-09
|
|
|
|
40
|
B011EK
|
LAMIVUDINE 150MG TAB (MAT/AHI)
|
LAMIVUDINE
|
LAMIVUDINE
|
30'S
|
BL
|
11.42
|
0.38
|
TABLET
|
0
|
TAB
|
MAT
|
MYLAN LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08180820
|
NRTI
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
40
|
B011EL
|
ABACAVIR 300MG CAP (MAT/AHI)
|
ABACAVIR
|
ABACAVIR
|
60'S
|
BL
|
47.57
|
0.79
|
CAPSULE
|
0
|
CAP
|
MAT
|
MYLAN LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08180820
|
NRTI
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
40
|
B011EM
|
ZIDOVIR 300MG CAP (CIP/AHI) ZIDOVUDINE
|
ZIDOVUDINE
|
ZIDOVIR
|
60'S
|
BL
|
61.87
|
1.03
|
CAPSULE
|
0
|
CAP
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08180820
|
NRTI
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
B011EP
|
APO-LAMIVUDINE 150MG TAB (APO) LAMI (BL)
|
LAMIVUDINE
|
APO-LAMIVUDINE
|
60'S
|
BL
|
75.57
|
1.2595
|
TAB
|
60
|
BOTT
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
08180820
|
NRTI
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
NRTI
|
|
|
|
|
41
|
B0126
|
ZIDOVUDINE 10MG/ML SOLN (MCP) (BL)
|
ZIDOVUDINE
|
ZIDOVUDINE
|
240ML
|
BL
|
39.93
|
0.1664
|
ML
|
100
|
BOTT
|
MCP
|
MACLEODS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08180820
|
NRTI
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
NRTI
|
|
|
|
|
41
|
B0127
|
LAMIVUDINE 10MG/ML SOLN (MCP) (BL)
|
LAMIVUDINE
|
LAMIVUDINE
|
240ML
|
BL
|
45.37
|
0.189
|
ML
|
0
|
BOTT
|
MCP
|
MACLEODS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08180820
|
NRTI
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
NRTI
|
|
